Skip to main content

Acne News

A cohort study revealed potassium monitoring is still prevalent in clinical practices regardless of sufficient evidence supporting the cessation of this practice.
Acne increases in prevalence among transgender patients following initiation of masculinizing hormone therapy, according to a study recently published in JAMA Dermatology.
A recent study published in Journal of the American Academy of Dermatology found that spironolactone improved clinical outcomes and was well tolerated over an extended duration in adult women with acne.
A recent randomized controlled trial assessed the efficacy of fusidic acid cream compared with erythromycin ointment as postoperative treatment following ablative fractional CO2 laser for acne scars.
A recent pooled analysis of two phase 3 randomized clinical trials showed a new once-daily lotion formulation was safe, effective, and well-tolerated among pediatric patients with moderate to severe acne.
In a recent study, researchers investigated the effects of a real-time, electronic, decision-support tool on the treatment of acne among primary care providers.
A recent study showed patients with mild acne experienced improvements in lesion counts after using a day and night formulation of licochalcone A for 8 weeks.
Findings from a recent study showed the prevalence of depression and anxiety were higher among people with acne, supporting the need for more aggressive treatment and psychiatric screening.
Researchers investigated the association between health care use and treatment and patient factors, including race/ethnicity and sex, among patients with acne.
Findings from a recent study showed a novel tazarotene 0.045% lotion formulation achieved treatment success and was well-tolerated among patients with moderate to severe acne.
Back to Top